These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34680391)

  • 1. Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities.
    Rauch M; Agaimy A; Semrau S; Willner A; Ott O; Fietkau R; Hohenberger W; Croner RS; Grützmann R; Fechner K; Vassos N
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
    Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
    Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
    Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
    Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.
    Hall KS; Bruland ØS; Bjerkehagen B; Lidbrink E; Jebsen N; Hagberg H; Papworth K; Hagberg O; Trovik C; Bauer H; Eriksson M
    Clin Sarcoma Res; 2020 Nov; 10(1):22. PubMed ID: 33292545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.
    Gingrich AA; Bateni SB; Monjazeb AM; Darrow MA; Thorpe SW; Kirane AR; Bold RJ; Canter RJ
    Ann Surg Oncol; 2017 Oct; 24(11):3252-3263. PubMed ID: 28741123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
    Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
    Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative radiotherapy with concomitant chemotherapy in extremity soft tissue sarcomas: long-term results of a single center.
    Yilmaz U; Kamer S; Kaya H; Sabah D; Sanli UA; Tamsel I; Yaman B; Akalin T; Anacak Y
    Strahlenther Onkol; 2023 Jun; 199(6):585-594. PubMed ID: 36725697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
    Willner A; Agaimy A; Fechner K; Ott O; Denz A; Weissmann T; Meidenbauer N; Höfler D; Gaipl U; Frey B; Schmidt M; Haller F; Horch R; Hartmann A; Grützmann R; Fietkau R; Semrau S
    Int J Hyperthermia; 2023; 40(1):2248424. PubMed ID: 37611915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities.
    Leite ETT; Munhoz RR; Camargo VP; Lima LGCA; Rebolledo DCS; Maistro CEB; Busnardo FF; Ferreira FO; Salvajoli JV; Carvalho HA
    Radiother Oncol; 2021 Aug; 161():222-229. PubMed ID: 34171452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
    Pasquali S; Palmerini E; Quagliuolo V; Martin-Broto J; Lopez-Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz-Beveridge R; Ferraresi V; Lugowska I; Infante G; Braglia L; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Miceli R; Casali PG; Gronchi A
    Cancer; 2022 Jan; 128(1):85-93. PubMed ID: 34643947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
    Roeder F; Lehner B; Schmitt T; Kasper B; Egerer G; Sedlaczek O; Grüllich C; Mechtersheimer G; Wuchter P; Hensley FW; Huber PE; Debus J; Bischof M
    BMC Cancer; 2014 May; 14():350. PubMed ID: 24885755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
    Fromm J; Klein A; Kirilova M; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
    BMC Cancer; 2024 Mar; 24(1):303. PubMed ID: 38448852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.
    Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT
    Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.
    Bedi M; King DM; Shivakoti M; Wang T; Zambrano EV; Charlson J; Hackbarth D; Neilson J; Whitfield R; Wang D
    Radiat Oncol; 2013 Mar; 8():60. PubMed ID: 23497372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative Radiotherapy After Limb-sparing Surgery for Soft-tissue Sarcomas of the Distal Extremities.
    Kim YJ; Song SY; Choi W; Je HU; Ahn JH; Chung HW; Lee JS
    Anticancer Res; 2016 Sep; 36(9):4825-31. PubMed ID: 27630336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
    Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B
    Cancer; 2010 Oct; 116(19):4613-21. PubMed ID: 20572040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
    Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y
    Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
    Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
    Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
    Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.